Concepedia

Publication | Closed Access

725MO Phase I study of the combination of the dual RAF/MEK inhibitor VS-6766 and the FAK inhibitor defactinib: Results of efficacy in low grade serous ovarian cancer

DOI

17

Citations

0

References

2021

Year

Susana Banerjee, Rafael Grochot, R. Shinde, João Paulo da Silveira Nogueira Lima, Matthew Krebs, R. Abdul Rahman, Martin Little, Nina Tunariu, Andra Curcean, Hannah Badham,
Annals of Oncology

No additional data available for this publication yet. Check back later!